Canada - English - Health Canada

accord healthcare inc - fluorouracil - solution - 50mg - fluorouracil 50mg - antineoplastic agents

Canada - English - Health Canada

biolyse pharma corporation - fluorouracil - solution - 0.5g - fluorouracil 0.5g - antineoplastic agents

Canada - English - Health Canada

biolyse pharma corporation - fluorouracil - solution - 5g - fluorouracil 5g - antineoplastic agents

Canada - English - Health Canada

generic medical partners inc - fluorouracil - solution - 250mg - fluorouracil 250mg - antineoplastic agents

Canada - English - Health Canada

generic medical partners inc - fluorouracil - solution - 500mg - fluorouracil 500mg - antineoplastic agents

Canada - English - Health Canada

generic medical partners inc - fluorouracil - solution - 1000mg - fluorouracil 1000mg - antineoplastic agents

Canada - English - Health Canada

generic medical partners inc - fluorouracil - solution - 5000mg - fluorouracil 5000mg - antineoplastic agents

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - fluorouracil -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - fluorouracil, quantity: 25 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - fluorouracil is indicated alone or in combination for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - fluorouracil, quantity: 50 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; water for injections - fluorouracil is indicated alone or in combination for the palliative treatment of malignant tumours, particularly of the breast, colon or rectum; and in the treatment of gastric, primary hepatic, pancreatic, uterine (cervical particularly), ovarian and bladder carcinomas. fluorouracil should only be used when other proven measures have failed or are considered impractical.